We are live on ! Find out more
Legal & General Group

Legal & General Group Portfolio holdings

AUM $432B
1-Year Est. Return 29.4%
 

Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.

This Quarter Est. Return
+9.31%
1 Year Est. Return
+29.4%
3 Year Est. Return
+97.7%
5 Year Est. Return
+129.51%
10 Year Est. Return
+472.83%
AUM
$210B
AUM Growth
+$20.2B
Cap. Flow
+$4.59B
Cap. Flow %
2.19%
Top 10 Hldgs %
17.72%
Holding
3,425
New
77
Increased
2,516
Reduced
317
Closed
57

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$261M
2
BABA icon
Alibaba
BABA
+$233M
3
TFC icon
Truist Financial
TFC
+$191M
4
MSFT icon
Microsoft
MSFT
+$160M
5
AMZN icon
Amazon
AMZN
+$133M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Financials 15.12%
3 Healthcare 12.68%
4 Consumer Discretionary 10.28%
5 Communication Services 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASX icon
3126
ASE Group
ASX
$85.1B
$24K ﹤0.01%
4,323
AVTX icon
3127
Avalo Therapeutics
AVTX
$980M
$24K ﹤0.01%
2
+1
+100% +$10.5K
BH icon
3128
Biglari Holdings Class B
BH
$1.23B
$24K ﹤0.01%
211
-22
-9% -$2.24K
CSTL icon
3129
Castle Biosciences
CSTL
$953M
$24K ﹤0.01%
689
+113
+20% +$2.76K
CTSO icon
3130
Cytosorbents Corp
CTSO
$23.7M
$24K ﹤0.01%
6,219
+1,196
+24% +$5.22K
IDT icon
3131
IDT Corp
IDT
$1.67B
$24K ﹤0.01%
3,274
+488
+18% +$3.51K
MBIO icon
3132
Mustang Bio
MBIO
$4.5M
$24K ﹤0.01%
8
+2
+33% +$4.58K
OTRK
3133
DELISTED
Ontrak
OTRK
$24K ﹤0.01%
16
+3
+23% +$4.14K
UBFO
3134
DELISTED
United Security Bancshares
UBFO
$24K ﹤0.01%
2,270
FNCB
3135
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$24K ﹤0.01%
2,877
PRTK
3136
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$24K ﹤0.01%
5,854
+1,151
+24% +$3.99K
PRTY
3137
DELISTED
Party City Holdco Inc.
PRTY
$24K ﹤0.01%
10,442
FCCY
3138
DELISTED
1st Constitution Bancorp
FCCY
$24K ﹤0.01%
1,100
GFN
3139
DELISTED
General Finance Corporation
GFN
$24K ﹤0.01%
2,172
+189
+10% +$1.86K
ALDX icon
3140
Aldeyra Therapeutics
ALDX
$93.5M
$23K ﹤0.01%
3,904
+622
+19% +$3.59K
HBB icon
3141
Hamilton Beach Brands
HBB
$321M
$23K ﹤0.01%
1,229
+259
+27% +$4.75K
ITRN icon
3142
Ituran Location and Control
ITRN
$1.12B
$23K ﹤0.01%
929
NINE
3143
DELISTED
Nine Energy Service
NINE
$23K ﹤0.01%
2,899
-418
-13% -$2.43K
NVAX icon
3144
Novavax
NVAX
$1.26B
$23K ﹤0.01%
5,733
-413
-7% -$1.79K
CMRX
3145
DELISTED
Chimerix, Inc.
CMRX
$23K ﹤0.01%
10,988
SBT
3146
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$23K ﹤0.01%
2,873
GSKY
3147
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$23K ﹤0.01%
2,610
PRVL
3148
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$23K ﹤0.01%
1,430
+228
+19% +$2.91K
AVXL icon
3149
Anavex Life Sciences
AVXL
$292M
$22K ﹤0.01%
8,688
+1,520
+21% +$3.99K
BLFS icon
3150
BioLife Solutions
BLFS
$1.59B
$22K ﹤0.01%
1,362
+256
+23% +$4.16K

Similar funds

Legal & General Group's Q4 2019 Portfolio in Review

As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
  • Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
  • Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
  • Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
  • Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
  • Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
  • Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.

Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.